Colorectal cancer (CRC) remains a leading cause of cancer-related morbidity and mortality worldwide. In recent years, molecular diagnostics have transformed CRC treatment, particularly through identification
Solid tumors with NTRK gene fusion represent a rare but actionable subset of malignancies driven by genetic alterations in neurotrophic receptor tyrosine kinase (NTRK) genes.
Pheochromocytoma Adjunct Therapy: Pheochromocytoma is a catecholamine-secreting tumor that primarily arises from the adrenal medulla. While surgical resection remains the cornerstone of treatment, adjunct therapies
Non small cell lung cancer with braf v600e mutation: Non-small cell lung cancer (NSCLC) represents the majority of lung cancer diagnoses worldwide, with several molecular
Neuregulin 1 gene fusion positive non small cell lung cancer (NRG1+ NSCLC) is a rare molecular subtype of NSCLC that involves the fusion of the
Metastatic urothelial carcinoma (mUC) is an advanced stage of urothelial cancer, primarily affecting the bladder but capable of spreading to distant organs such as the
Metastatic malignant melanoma is an advanced stage of skin cancer where melanoma cells spread beyond the original tumor site to other parts of the body.